相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A phase 2 study of Rituximab-Bendamustine and Rituximab-Cytarabine for transplant-eligible patients with mantle cell lymphoma
Philippe Armand et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
The addition of sirolimus to the graft-versus-host disease prophylaxis regimen in reduced intensity allogeneic stem cell transplantation for lymphoma: a multicentre randomized trial
Philippe Armand et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing
David M. Kurtz et al.
BLOOD (2015)
Detection of classical Hodgkin lymphoma specific sequence in peripheral blood using a next-generation sequencing approach
Yasuhiro Oki et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study
Mark Roschewski et al.
LANCET ONCOLOGY (2015)
Immunoglobulin and T Cell Receptor Gene High-Throughput Sequencing Quantifies Minimal Residual Disease in Acute Lymphoblastic Leukemia and Predicts Post-Transplantation Relapse and Survival
Aaron C. Logan et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
Sally F. Barrington et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Autologous or Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Chemotherapy-Sensitive Mantle-Cell Lymphoma: Analysis of Transplantation Timing and Modality
Timothy S. Fenske et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders
M. Ladetto et al.
LEUKEMIA (2014)
Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission
Roland B. Walter et al.
BLOOD (2013)
The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMT
S. P. Robinson et al.
BONE MARROW TRANSPLANTATION (2013)
Detection of circulating tumour DNA in patients with aggressive B-cell non-Hodgkin lymphoma
Philippe Armand et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Hematopoietic Cell Transplantation for Systemic Mature T-Cell Non-Hodgkin Lymphoma
Sonali M. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Minimal residual disease quantification using consensus primers and high- throughput IGH sequencing predicts post-transplant relapse in chronic lymphocytic leukemia
A. C. Logan et al.
LEUKEMIA (2013)
Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?
Ulrike Bacher et al.
BLOOD (2012)
Massive evolution of the immunoglobulin heavy chain locus in children with B precursor acute lymphoblastic leukemia
Charles Gawad et al.
BLOOD (2012)
Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia
Malek Faham et al.
BLOOD (2012)
Minimal Residual Disease Quantification Is an Independent Predictor of Progression-Free and Overall Survival in Chronic Lymphocytic Leukemia: A Multivariate Analysis From the Randomized GCLLSG CLL8 Trial
Sebastian Boettcher et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Allogeneic stem cell transplantation for chronic lymphocytic leukemia: Lessons to be learned from minimal residual disease studies
Sebastian Boettcher et al.
BLOOD REVIEWS (2011)
Minimal residual disease detection in lymphoma and multiple myeloma: impact on therapeutic paradigms
Simone Ferrero et al.
HEMATOLOGICAL ONCOLOGY (2011)
Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial
Peter Dreger et al.
BLOOD (2010)
If it is in the marrow, is it also in the blood? An analysis of 1,000 paired samples from patients with B-cell non-Hodgkin lymphoma
Patrizia Mancuso et al.
BMC CANCER (2010)
Risk-Adapted Dose-Dense Immunochemotherapy Determined by Interim FDG-PET in Advanced-Stage Diffuse Large B-Cell Lymphoma
Craig H. Moskowitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Projected Cancer Risks From Computed Tomographic Scans Performed in the United States in 2007
Amy Berrington de Gonzalez et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Unrelated Donor Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma
Marcel P. Devetten et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Qualitative and quantitative polymerase chain reaction monitoring of minimal residual disease in relapsed chronic lymphocytic leukemia: early assessment can predict long-term outcome after reduced intensity allogeneic transplantation
Lucia Farina et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Favorable Long-Term Survival After Reduced-Intensity Allogeneic Transplantation for Multiple-Relapse Aggressive Non-Hodgkin's Lymphoma
Kirsty J. Thomson et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin lymphoma: Importance of histology for outcome
Philippe Armand et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Quantitative MRD monitoring identifies distinct GVL response patterns after allogeneic stem cell transplantation for chronic lymphocytic leukemia:: results from the GCLLSG CLL3X trial
M. Ritgen et al.
LEUKEMIA (2008)
Outcomes after allogenic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia
Mohamed L. Sorror et al.
BLOOD (2008)
Current concepts - Computed tomography - An increasing source of radiation exposure
David J. Brenner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Quantitative analysis of minimal residual disease predicts relapse in children with B-lineage acute lymphoblastic leukemia in DFCI ALL Consortium Protocol 95-01
Jianbiao Zhou et al.
BLOOD (2007)
Molecular relapse in adult standard-risk ALL patients detected by prospective MRD monitoring during and after maintenance treatment:: data from the GMALL 06/99 and 07/03 trials
Thorsten Raff et al.
BLOOD (2007)
Clinical significance of minimal residual disease, as assessed by different techniques, after stem cell transplantation for chronic lymphocytic leukemia
Carol Moreno et al.
BLOOD (2006)
Long-term follow-up of indolent lymphoma patients treated with high-dose sequential chemotherapy and autografting: Evidence that durable molecular and clinical remission frequently can be attained only in follicular subtypes
P Corradini et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL): predictive role of minimal residual disease monitoring on relapse
M Miglino et al.
BONE MARROW TRANSPLANTATION (2002)
分享论文
